EUVIMEDEUVIMED entdecken
Crossref

Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications

Igor Odintsov, Stephanie E Siegmund, Federica Pecci, Biagio Ricciuti, Jaclyn LoPiccolo, Jacob M Sands, Charlotte I Wang, Lynette M Sholl, Fei Dong

Modern Pathology · 2026-05 · 39 (5) · 100985

DOI: 10.1016/j.modpat.2026.100985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-05. Verfasst von Igor Odintsov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: iodintsov@bwh.harvard.edu. Hauptthemen laut MEDLINE: Lung Neoplasms, High-Throughput Nucleotide Sequencing, Carcinoma, Squamous Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHigh-Throughput Nucleotide SequencingCarcinoma, Squamous CellBiomarkers, TumorHumansMaleFemaleMiddle AgedAgedAged, 80 and overAdult

Stichwörter der Autor:innen

genomicslung squamous cell carcinomanext-generation sequencingnon–small cell lung carcinomatargeted therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: iodintsov@bwh.harvard.edu.
  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Department of Pathology, Stanford University School of Medicine, Palo Alto, California.

Zitieren

APA

Odintsov, I., Siegmund, S. E., Pecci, F., Ricciuti, B., LoPiccolo, J., Sands, J. M., Wang, C. I., Sholl, L. M., & Dong, F. (2026). Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications. Modern Pathology, 39(5), 100985. https://doi.org/10.1016/j.modpat.2026.100985

Vancouver

Odintsov I, Siegmund SE, Pecci F, Ricciuti B, LoPiccolo J, Sands JM, et al. Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications. Modern Pathology. 2026;39(5):100985. doi:10.1016/j.modpat.2026.100985

BibTeX
@article{Odintsov2026,
  author = {Odintsov, Igor and Siegmund, Stephanie E and Pecci, Federica and Ricciuti, Biagio and LoPiccolo, Jaclyn and Sands, Jacob M and Wang, Charlotte I and Sholl, Lynette M and Dong, Fei},
  title = {Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {5},
  pages = {100985},
  doi = {10.1016/j.modpat.2026.100985}
}
Kostenlos starten →